Objectives: To assess the frequency of successful Percutaneous Balloon Mitral Valvuloplasty (PBMV) and immediate post-procedure outcomes in patients with severe rheumatic mitral stenosis (SRMS). Methodology: This descriptive cross-sectional study was conducted at the Department of Cardiology at a tertiary care hospital, from 1st January 2018 to 31st December 2019. According to inclusion criteria, 200 patients with severe symptomatic mitral stenosis (SSMS) wer e recruited in the study, and written informed permission was acquired from patients or next of kin. Pre- and post-PBMV mitral valve area (MVA) and hemodynamics were recorded. Data were retrieved from the hospital chart record and collected on a pre -designed proforma. Results: In 176 (88%, n=200) patients mean MVA following PBMV increased from 0.93±0.31 cm2 to 1.73±0.16 cm2 (p ?0.05) and mean pulmonary artery systolic pressure (PASP) reduced from 56.62 mmHg ± 16.02 to 30.37±7.30 mmHg (p<0.05). Perioperative complications included severe mitral regurgitation (MR) in 2 (1%, n=200), moderate MR in 40 (20%, n=200), thromboembolic cerebrovascular accident in 1 (0.5%, n=200), pericardial effusion in 4 (2%, n=200), and new-onset atrial fibrillation in11 (5.5%, n=200), however, there was no mortality related to the procedure. Conclusion: PBMV was effective with reasonable immediate post-procedure outcomes in 88% of patients. However, efficacy can be increased by selecting patients with favourable valve morphology for PBMV.